KinoPharma and National Institutes for Quantum and Radiological Science and Technology Launch Collaborative Research Project for Exploring New Drug Development for Alzheimer’s Disease
Date: Aug. 29, 2018
Source: KinoPharma, Inc.
KinoPharma, Inc., and the National Institutes for Quantum and Radiological Science and Technology are pleased to announce that they have entered a contract for collaborative research on efficacy evaluation of the compound KPO1143, developed by KinoPharma, to prevent the accumulation of protein called tau (hereafter “tau protein”) (*1), which is considered a cause of Alzheimer’s disease (AD).
Continue reading »
